Latest Acquisition News

Apiam Animal Health reported a challenging FY25 with underperformance in its core clinical segment but has rebounded strongly in Q1 FY26. The company is now poised for acquisition by Adamantem Capital, offering shareholders a premium cash and scrip deal.

Raiden Resources has acquired an 85% commercial interest in the Crixás Gold Tailings Project in Brazil, aiming to unlock near-term, low-capital gold production through tailings reprocessing. The project features existing infrastructure and a third-party processing plant, with a feasibility study underway for a larger gravity processing facility.

GreenX Metals has validated historical copper grades at its Tannenberg Project in Germany with modern assays revealing thicker mineralisation than previously estimated, underscoring significant resource potential.

Brightstar Resources has received court approval to acquire Aurumin Limited, consolidating the Sandstone Gold Project and boosting its combined mineral resource to 2.4 million ounces. The acquisition positions Brightstar as a rising mid-tier gold producer in Western Australia.

Cash Converters has completed a $25 million equity raise to fund the acquisition of 29 Australian franchise stores, with EZCORP increasing its voting power to nearly 44%.

The Supreme Court of Western Australia has approved Brightstar Resources’ acquisition of Aurumin Limited, setting the stage for Aurumin’s shares to be suspended and delisted from the ASX by early December.

Auric Mining has secured four key tenements near Kalgoorlie for its Lindsay’s Gold Project, with further payments and share issuance contingent on a pending court ruling.

DevEx Resources has secured nine uranium exploration licences from Rio Tinto in the Northern Territory’s Alligator Rivers Uranium Province, significantly enlarging its exploration territory near historic high-grade deposits.

Lloyds Banking Group is set to acquire London-based fintech Curve, aiming to enhance its mobile banking with advanced digital wallet features. The deal, expected to close in early 2026, marks a strategic push in Lloyds’ digital transformation journey.

The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition, ordering Cosette Pharmaceuticals to comply with conditions preventing closure of the Salisbury manufacturing site. This ruling highlights concerns over market transparency and the integrity of the takeover process.

The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition after Cosette Pharmaceuticals changed its intentions to close the Salisbury manufacturing site, raising concerns over market transparency and regulatory approval.

Astron Limited has received a pivotal Australian Taxation Office Class Ruling confirming capital gains tax roll-over relief for shareholders following its redomicile from Hong Kong to Australia. This development streamlines the company’s structure and offers potential long-term benefits to investors.